Dacarbazine meda powder for solution for injection infusion – Change to required period of contraception for female patients
29/02/2024
Medicines for human use
Product information update (PIU)
This update is to inform healthcare professionals of a recent update to the product information for Dacarbazine medac, powder for solution for injection/infusion. This update relates to the required period of contraception for female patients of reproductive potential.
Please see the document linked below for further information.
Product name or type:
- Dacarbazine medac 200 mg, powder for solution for injection/infusion (PA0623/003/002)
- Dacarbazine medac 500 mg, powder for solution for injection/infusion (PA0623/003/003)
- Dacarbazine medac 1000 mg, powder for solution for injection/infusion (PA0623/003/004)
Product information
- Active substance
- Dacarbazine
- Authorisation holder
- Medac
- Authorisation number
-
PA0623/003/002-004
- Human or veterinary medicine
- Human Medicine